Cargando…
Thalidomide for Patients with β-Thalassemia: A Multicenter Experience
OBJECTIVE: This study focused on the efficacy and safety of thalidomide for patients with β-thalassemia in a multicenter trial. METHODS: Patients with non-transfusion-dependent thalassemia (NTDT) or transfusion-dependent thalassemia (TDT), who were unable to pursue conventional therapy with transfus...
Autores principales: | Yang, Kun, Wu, Yi, Zhou, Yali, Long, Binbin, Lu, Qian, Zhou, Tianhong, Wang, Li, Geng, Zhili, Yin, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202343/ https://www.ncbi.nlm.nih.gov/pubmed/32395210 http://dx.doi.org/10.4084/MJHID.2020.021 |
Ejemplares similares
-
Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022) -
The Clinical Significance of the Spectrum of Interactions of the Rare IVS-II-5 G>C (HBB: c.315+5 G>C) Variation with Other β-Thalassemia Mutations in Southern China
por: Liao, Guiping, et al.
Publicado: (2022) -
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Chen, Jiang-Ming, et al.
Publicado: (2021) -
Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report
por: Javed, Rizwan, et al.
Publicado: (2020) -
Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
por: Chen, Yaocheng, et al.
Publicado: (2020)